The new report by Expert Market Research titled, ‘Global Generic Drugs Market Report and Forecast 2024-2032’, gives an in-depth analysis of the Global Generic Drugs Market, assessing the market based on its segments like drug delivery, applications, distribution channels and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/generic-drug-market/requestsample
The key highlights of the report include:
Market Overview (2018-2032)
- Historical Market Size (2023): USD 370 Billion
- Forecast CAGR (2023-2032): 5.5%
- Forecast Market Size (2032): USD 510.2 Billion
The substantial increase in cardiometabolic risk factors among the population is driving the global generic drugs market. Furthermore, diabetes, dyslipidaemia, hypertension, metabolic syndrome, and obesity are becoming more common because of various factors such as changing dietary habits, sedentary lifestyles, and hectic work schedules. This has resulted in a major increase in the uptake of medicines, accelerating the industry’s growth.
Generic Drugs Industry Definition and Major Segments
Based on efficacy, strength, consistency, durability, effects, intended usage, dosage type, and route of administration, generic drugs are referred to as the bioequivalent of brand-name drugs. These medications have been shown to be safe and successful in the same way as their brand-name counterparts have been. Generic drug manufacturers are not expected to invest in drug discovery, production, or marketing, which makes these drugs more affordable and contributes to their popularity.
Explore full report with table of contents: https://www.expertmarketresearch.com/reports/generic-drug-market
Based on application, the generic drugs market is divided into:
Based on drug delivery, the industry is segmented into:
Based on distribution channel, the industry is categorised into:
- Retail Pharmacies
- Hospital Pharmacies
Based on region, the market is divided into:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Generic Drugs Market Trends
The global generic drugs market is boosted by the high prices associated with the treatment of numerous chronic and lifestyle disorders, which has led to a shift in customer preference for lower-cost alternatives, boosting demand even further. Apart from that, the industry is expected to expand due to the patent expiration of key blockbuster drugs, as well as a range of favourable steps taken by governments in several countries to promote the use of generic drugs. Several regulatory authorities are conducting thorough investigations to ensure that these drugs are manufactured to the highest possible standards.
Key Market Players
The major players in the market are Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis AG, Sun Pharmaceutical Industries Ltd., and Fresenius Kabi AG. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person:-Ian Bell, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA